Literature DB >> 14624301

How complete is successful? "Autologous retinal pigment epithelium and choriod translocation in patients with exsudative age-related macular degeneration: a short-term follow-up" by Jan van Meurs and P.R. van Biesen.

Antonia M Joussen1.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 14624301     DOI: 10.1007/s00417-003-0792-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  14 in total

1.  A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring.

Authors:  G A Peyman; K J Blinder; C L Paris; W Alturki; N C Nelson; U Desai
Journal:  Ophthalmic Surg       Date:  1991-02

2.  Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes.

Authors:  Y Ninomiya; J M Lewis; T Hasegawa; Y Tano
Journal:  Am J Ophthalmol       Date:  1996-11       Impact factor: 5.258

3.  The prevalence of macular drusen in postmortem eyes.

Authors:  A J Coffey; S Brownstein
Journal:  Am J Ophthalmol       Date:  1986-08-15       Impact factor: 5.258

4.  Ultrastructural features of surgically excised idiopathic subfoveal neovascular membranes.

Authors:  J W Thomas; H E Grossniklaus; H M Lambert; T M Aaberg; N L'Hernault
Journal:  Retina       Date:  1993       Impact factor: 4.256

5.  The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

Authors:  H M Leibowitz; D E Krueger; L R Maunder; R C Milton; M M Kini; H A Kahn; R J Nickerson; J Pool; T L Colton; J P Ganley; J I Loewenstein; T R Dawber
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

6.  Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results.

Authors:  A S Berger; H J Kaplan
Journal:  Ophthalmology       Date:  1992-06       Impact factor: 12.079

7.  [Surgical removal of submacular neovascularization membranes].

Authors:  C Eckardt
Journal:  Ophthalmologe       Date:  1996-12       Impact factor: 1.059

8.  Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy.

Authors:  P V Algvere; L Berglin; P Gouras; Y Sheng; E D Kopp
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

9.  Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study.

Authors:  A Scheider; O Gündisch; A Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-01       Impact factor: 3.117

10.  Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization.

Authors:  P V Algvere; L Berglin; P Gouras; Y Sheng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-12       Impact factor: 3.117

View more
  4 in total

1.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

2.  Performing subretinal injections in rodents to deliver retinal pigment epithelium cells in suspension.

Authors:  Peter D Westenskow; Toshihide Kurihara; Stephen Bravo; Daniel Feitelberg; Zack A Sedillo; Edith Aguilar; Martin Friedlander
Journal:  J Vis Exp       Date:  2015-01-23       Impact factor: 1.355

Review 3.  Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.

Authors:  P Fernández-Robredo; A Sancho; S Johnen; S Recalde; N Gama; G Thumann; J Groll; A García-Layana
Journal:  J Ophthalmol       Date:  2014-01-14       Impact factor: 1.909

Review 4.  Stem cell therapies for age-related macular degeneration: the past, present, and future.

Authors:  Yalong Dang; Chun Zhang; Yu Zhu
Journal:  Clin Interv Aging       Date:  2015-01-14       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.